URSINI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 4.163
AS - Asia 2.718
EU - Europa 1.090
SA - Sud America 631
AF - Africa 92
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.729
Nazione #
US - Stati Uniti d'America 4.071
SG - Singapore 959
CN - Cina 662
BR - Brasile 515
VN - Vietnam 357
HK - Hong Kong 220
IT - Italia 191
TR - Turchia 157
DE - Germania 146
PL - Polonia 123
UA - Ucraina 120
GB - Regno Unito 107
FR - Francia 81
ID - Indonesia 76
RU - Federazione Russa 74
SE - Svezia 58
IN - India 53
JP - Giappone 51
FI - Finlandia 47
AR - Argentina 46
ZA - Sudafrica 44
MX - Messico 40
CA - Canada 37
BD - Bangladesh 33
AU - Australia 30
IQ - Iraq 29
EC - Ecuador 25
AT - Austria 22
NL - Olanda 20
IE - Irlanda 19
CO - Colombia 18
PK - Pakistan 18
BE - Belgio 12
CH - Svizzera 12
ES - Italia 12
TN - Tunisia 11
MY - Malesia 10
PH - Filippine 10
UZ - Uzbekistan 10
KE - Kenya 8
LT - Lituania 8
MA - Marocco 8
SA - Arabia Saudita 8
VE - Venezuela 8
KR - Corea 7
PY - Paraguay 7
CL - Cile 6
KZ - Kazakistan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
LB - Libano 5
NP - Nepal 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EE - Estonia 4
IR - Iran 4
PT - Portogallo 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
CG - Congo 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
IL - Israele 3
KW - Kuwait 3
NO - Norvegia 3
OM - Oman 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
EG - Egitto 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
Totale 8.719
Città #
Fairfield 592
Ashburn 536
Singapore 509
Woodbridge 299
Santa Clara 294
Seattle 278
Houston 230
Wilmington 226
San Jose 208
Hong Kong 207
Beijing 201
Cambridge 192
Izmir 138
Ho Chi Minh City 121
Warsaw 121
Hanoi 83
Dallas 79
Princeton 64
Milan 62
Nanjing 61
Jacksonville 60
Ann Arbor 57
Lauterbourg 54
Jakarta 53
São Paulo 48
Tokyo 48
Helsinki 44
Los Angeles 42
Chandler 40
New York 40
San Diego 37
London 26
Council Bluffs 25
Mexico City 24
Redwood City 23
Shanghai 23
Dong Ket 20
Hangzhou 20
Johannesburg 20
Nanchang 19
Shenyang 19
Dublin 18
Ferrara 17
Nuremberg 17
Chennai 16
Orem 16
Rome 16
Baghdad 15
Chicago 15
Da Nang 15
Melbourne 14
Rio de Janeiro 14
Tianjin 14
Hebei 13
Moscow 13
San Francisco 13
Toronto 13
Munich 12
Norwalk 12
Biên Hòa 11
Brooklyn 11
Frankfurt am Main 11
Montreal 11
Poplar 11
Denver 10
Guangzhou 10
Atlanta 9
Boston 9
Carbonia 9
Duque de Caxias 9
Guayaquil 9
Haiphong 9
Jiaxing 9
Ningbo 9
Vienna 9
Falls Church 8
Tashkent 8
Belo Horizonte 7
Changsha 7
Curitiba 7
Kuala Lumpur 7
Manaus 7
Manchester 7
Mountain View 7
Stockholm 7
Sydney 7
Amsterdam 6
Bến Tre 6
Paris 6
Porto Alegre 6
Addis Ababa 5
Brasília 5
Bắc Ninh 5
Campinas 5
Can Tho 5
Cattolica 5
Chongqing 5
Dhaka 5
Guarulhos 5
Jeddah 5
Totale 5.815
Nome #
Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis 506
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 222
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 186
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis 182
Assessing Pretest Clinical Risk of Pulmonary Thromboembolism in the Emergency Department: Proposal of a Simple Modification to the Wells' Score 179
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: A systematic review and meta-analysis 174
Cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients 171
Abatacept in psoriatic arthritis: Case report and short review 167
The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review 165
Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain 163
Current treatment options for psoriatic arthritis: Spotlight on abatacept 160
Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features 158
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 155
Correlation between elastosonography and nailfold microvascular alterations in systemic sclerosis patients 154
Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study 154
Complement C3 is the strongest predictor of whole-body insulin sensitivity in psoriatic arthritis 153
Safety of treatment options for spondyloarthritis: a narrative review 153
Acute rhabdomyolysis during treatment with amisulpride and metformin 151
Predicting in-hospital mortality for sepsis: a comparison between qSOFA and modified qSOFA in a 2-year single-centre retrospective analysis 147
The emerging role of complement c3 as a biomarker of insulin resistance and cardiometabolic diseases: Preclinical and clinical evidence 145
CD4+ T-cells lymphocytosis and reduction of neutrophils during treatment with adalimumab: Challenge and dechallenge study 143
Biologic drugs in adult onset Still’s disease: a systematic review and meta-analysis of observational studies 141
Chronobiology of acute pancreatitis in a single Italian centre 141
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 140
Levels and Factors Associated with Resilience in Italian Healthcare Professionals during the COVID-19 Pandemic: A Web-Based Survey 140
Metformin and Autoimmunity: A "New Deal" of an Old Drug 139
Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients 139
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 135
Fibromyalgia and obesity: The hidden link 134
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 133
Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function 129
Efficacy and safety of duloxetine in fibromyalgia 127
Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis 126
Methods for diagnosing bile acid malabsorption: a systematic review 126
Kaposi's sarcoma after T-cell costimulation blockade with abatacept in rheumatoid arthritis: a case report 125
Brain glucose consumption abnormalities in neuro-Behçet's disease: A preliminary 18F-FDG PET/CT study 124
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 124
Serum complement C3 and type 2 diabetes in rheumatoid arthritis: A case-control study 124
Nutritional supplementation for osteoarthritis 123
Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy 123
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo 122
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 120
High prevalence of achilles tendon enthesopathic changes in patients with type 2 diabetes without peripheral neuropathy 119
Role of positron emission tomography for central nervous system involvement in systemic autoimmune diseases: Status and perspectives 119
TNF-alpha and insulin-resistance: Metabolic effects of in vivo therapeutic blockade 118
Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab 117
Old but good: Modified-release prednisone in rheumatoid arthritis 117
Infliximab and insulin resistance 113
Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab 113
Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort 112
Cardiometabolic comorbidities in autoimmune rheumatic diseases: From pathogenesis to treatment 112
Improvement in insulin resistance after short-term treatment with abatacept: Case report and short review 108
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 107
Insulin-sensiting effects of tumor necrosis factor alpha inhibitors in rheumatoid arthritis: A systematic review and meta-analysis 105
Ageing effect on 18 F-DOPA and 123 I-MIBG uptake: A cross-sectional study 105
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 92
Increased serum IgG antibody response to Merkel cell polyomavirus oncoproteins in patients with autoimmune rheumatic diseases 92
Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis 88
Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on “Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study” by Tseng et al., Joint Bone Spine 2016;83:307–13 88
Prevalence of undiagnosed diabetes in rheumatoid arthritis: An OGTT study 86
Prevalence of celiac disease serological markers in a cohort of Italian rheumatological patients 82
Response to the letter to the editor by Shadmani et al 82
The effect of non–TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis 76
The HPA Axis in the pathogenesis of Chronic Fatigue Syndrome 73
Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey 68
Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis 66
Totale 8.881
Categoria #
all - tutte 47.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 125 55 62
2021/2022539 27 42 18 36 40 38 15 61 26 65 43 128
2022/2023233 65 7 22 4 4 8 64 16 16 1 19 7
2023/2024201 15 26 13 7 8 7 9 10 5 2 7 92
2024/20251.422 15 44 121 23 163 185 24 76 207 312 143 109
2025/20263.686 300 297 476 631 496 216 255 259 358 398 0 0
Totale 8.881